Study the usefulness of cartridge based NUCLEIC acid amplification test in bronchoalveolar lavage samples in the diagnosis of smear-negative/non sputum producing patients with suspected tuberculosis

Authors

  • K. Raj Kumar Department of Pulmonary Medicine, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
  • Sony Reddy Department of Pulmonary Medicine, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
  • Raghu Vamsi Department of Pulmonary Medicine, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20190942

Keywords:

Amplification test, Bronchoalveolar lavage, Pulmonary tuberculosis, Sputum negative

Abstract

Background: The aim of study is to evaluate the diagnostic value of the CBNAAT in BAL samples of smear negative for AFB or who could not produce an expectorated sputum sample.

Methods: A prospective and observational study of in patient and out patient department in Department of Pulmonary Medicine of Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar during the period November 2017 to November 2018.

Results: Bronchoalveolar lavage cartridge based nucleic acid amplification test in bronchoalveolar lavage was done for 60 samples of patients who were having history and chest x-ray suggestive of pulmonary tuberculosis with sputum AFB negative. Out of these sputum negative samples 25 were BAL CBNAAT positive and rest were negative.

Conclusions: CBNAAT adds significantly to the diagnostic yield of PTB in comparison to sputum smear microscopy. It has additional advantage of identifying rifampicin resistance with high sensitivity and specificity.

Author Biography

Sony Reddy, Department of Pulmonary Medicine, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

-

References

World Health Organization. Global tuberculosis report Geneva: WHO, 2014. Available at: https://apps.who.int/iris/bitstream/handle/10665/137094/9789241564809_eng.pdf?sequence=1&isAllowed=y.

Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis. 2006;6(11):710-25.

Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. The Lancet. 2007 Jun 16;369(9578):2042-9.

Moore DF, Guzman JA, Mikhail LT. Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis. 2005;52(3):247-54.

Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006;6(3):423-32.

Central TB division (India). Revised National TB Control Programme. Technical and Operational Guidelines for Tuberculosis Control in India; 2016.

Wong CF, Yew WW, Chan CY, Au LY, Cheung SW, Cheng AF. Rapid diagnosis of smear-negative pulmonary tuberculosis via fibreoptic bronchoscopy: utility of polymerase chain reaction in bronchial aspirates as an adjunct to transbronchial biopsies. Respir Med. 1998;92:815-9.

Chen NH, Liu YC, Tsao TC, Wu TL, Hsieh MJ, Chuang ML, Combined bronchoalveolar lavage and polymerase chain reaction in the diagnosis of pulmonary tuberculosis in smear-negative patients. Int J Tuberc Lung Dis. 2002;6:350-5.

World Health Organization: WHO report 2010: global tuberculosis control. Geneva, Switzerland: WHO; 2010.

Downloads

Published

2019-02-27

How to Cite

Kumar, K. R., Reddy, S., & Vamsi, R. (2019). Study the usefulness of cartridge based NUCLEIC acid amplification test in bronchoalveolar lavage samples in the diagnosis of smear-negative/non sputum producing patients with suspected tuberculosis. International Journal of Research in Medical Sciences, 7(3), 886–888. https://doi.org/10.18203/2320-6012.ijrms20190942

Issue

Section

Original Research Articles